Fellowships - INVEST Drug Abuse Research Fellowship

The INVEST Drug Abuse Research Fellowship combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug abuse scientists. Fellows may conduct their research in any aspect of the biomedical or behavioral science of drug abuse and addiction. Previous Fellows have conducted research in all aspects of drug abuse and addiction, from social science to basic science, including epidemiology, prevention, treatment, and preclinical and clinical sciences. Fellows and their mentors are encouraged to develop jointly and seek funding for a collaborative research project to be conducted in the Fellow's home country. Fellows and their U.S. mentors are part of a network of international scientists who exchange information and collaborate on drug abuse research nationally, regionally, and globally.

What Does the Fellowship Include?

The 12-month fellowship provides –

• Rigorous postdoctoral research training with a NIDA grantee at a U.S. institution.
• Professional development activities that help you establish personal relationships with NIDA grantees and NIDA officials who are willing to continue working with you after you return home.
• A stipend of $36,000US for living and personal expenses, round-trip travel, and a $4,000US allowance to cover the cost of health insurance and professional development activities.

Who Is Eligible?

The requirements for INVEST applicants are –

• An earned doctoral degree in medicine, public health, biomedical, behavioral, or social sciences.
• A minimum of 2 years of postdoctoral research experience, including a demonstrated ability to engage in independent research.
• Written assurance from an institution in the home country that there is a position to which the applicant can return after completing the fellowship.
• Proficiency in written and spoken English.
• Citizenship or permanent residency in a country other than the United States.
• Status of living and working outside the United States at the time the application is submitted.
• Eligibility for the J-1 visa to enter the United States.

How Should I Apply?

The INVEST Drug Abuse Research Fellowship application requires careful and thorough coordination between the applicant and mentor:

• Contact a NIDA-supported researcher in the United States who is willing to serve as a mentor. The mentor must be a current NIDA grantee.
• Notify the NIDA International Program of your plans to apply.
• Write a detailed research plan for working with the U.S. mentor on biomedical or behavioral research investigating the causes, consequences, prevention, or treatment of drug abuse and addiction.
• Complete and submit your application to the NIDA International Program.

How Can I Get Help in Finding a Mentor?

To find the Mentor who's right for you, consult the online database of research projects supported by NIH at http://crisp.cit.nih.gov, review journals online at PubMed at http://www.ncbi.nlm.nih.gov, or email the NIDA International Program for assistance at ip@nida.nih.gov.

Application Deadlines: April 1 and October 1
Notification of Award: June 1 and December 1

Instruction and application materials for the INVEST Drug Abuse Research Fellowship can be downloaded from this Web site in Microsoft Word and Adobe PDF format:

• INVEST Drug Abuse Research Fellowship Instruction Packet
  PDF Format     (237KB)
  MS Word Format   (88KB)
• INVEST Drug Abuse Research Fellowship Application Packet
  PDF Format     (205KB)
  MS Word Format   (262KB)
  
• Download INVEST Drug Abuse Research Fellowship Brochure:
  INVEST Drug Abuse Research Fellowship Brochure     (2.7MB)

Who has been an INVEST Drug Abuse Research Fellow and Mentor?

Year	Fellow	Mentor
2008-2009	Sheng Liu China	Dr. Gary S. Aston-Jones Medical University of South Carolina
2007-2008	Jiang Du China	Dr. Hser Yih-Ing University of California, Los Angeles
	Akiko Shimamoto Kiyoshima Japan	Dr. Klaus A. Miczek Tufts University
	Adhi Wibowo Nurhidayat Indonesia	Dr. George Woody University of Pennsylvania
	Wenhua Zhou China	Dr. Peter Kalivas Medical University of South Carolina
2006-2007	Paula M. Mayock Ireland	Michael C. Clatts, Ph.D. National Development & Research Institutes, Inc., New York
	Paulo Roberto Telles P. Diaz Brazil	Kimberly Page Shafer, Ph.D. Institute for Global Health/CAPS, University of California, San Francisco, Department of Medicine
	Wagner Alves de Souza Judice Brazil	Dr. Iris Lindberg Louisiana State University
	Doug Hyun Han South Korea	Perry F. Renshaw, M.D., Ph.D. Director, McLean Brain Imaging Center and Professor of Psychiatry at Harvard Medical School, Belmont, Massachusetts
	Sung-Jin Cho South Korea	Alan P. Kozikowski, Ph.D. University of Illinois at Chicago
2005-2006	Tsafrir Loebl Israel	Eden Evans Addictions Research Program Massachusetts General Hospital
	Oscar Quintela Spain	Dennis Crouch Center for Human Toxicology University of Utah J. Michael Walsh The Walsh Group
	Maciej Stasiak Poland	Nicholas E. Goeders LSU Health Sciences Center - Shreveport
	Young Hoon Sung South Korea	Perry F. Renshaw McLean Brain Imaging Center
2004-2005	Marco Bortolato Italy	Daniele Piomelli University of California, Irvine
	Lan Zhang China	Kenneth Kendler Virginia Commonwealth University
	Liliana Cancela Argentina	Peter W. Kalivas Medical University of South Carolina
2003-2004	Marjaterttu Pajulo Finland	Linda C. Mayes Yale University School of Medicine, Connecticut
	Yufeng Chen China	Alan P. Kozikowski University of Illinois in Chicago, Chicago
2002-2003	Isabelle Husson France	Barry E. Kosofsky Harvard Medical School - Massachusetts General Hospital East
	Tamo Nakamura Australia	Anthony A. Wright University of Texas Medical School at Houston
	Yilang Tang China	Joseph Cubells Yale University School of Medicine, Connecticut
2001-2002	Debasish Basu India	Joel Gelernter Yale University, Connecticut
	Patricia Obando Costa Rica	Dace Svikis, Ph.D. Virginia Commonwealth University
	Tatiana Tsarouk Russia	Elaine Thompson University of Washington, Washington State
	Min Zhao China	Howard Liddle University of Miami, Florida
2000-2001	Henrik Druid Sweden	Deborah C. Mash University of Miami School of Medicine, Florida
	Chuang Liu China	Elliot A. Stein Medical College of Wisconsin, Milwaukee
1999-2000	Abdel Azim Assi Egypt	Charles I. Chavkin University of Washington, Seattle
	Elisa Mengual Spain	Virginia M. Pickel Weill Medical College, Cornell University, New York
	Vaughan Rees Australia	Jeffrey H. Samet Boston University School of Medicine
1998-1999	You Wan China	Jeffrey S. Mogil University of Illinois at Champaign-Urbana
	Neo Morojele South Africa	Judith S. Brook Mt. Sinai School of Medicine, New York
1997-1998	Guilherme Borges Mexico	Ronald C. Kessler Harvard Medical School, Boston
	Yulia Lyupina Russia	James E. Smith Wake Forest University, North Carolina
	Olivier Manzoni France	John T. Williams Oregon Health Sciences University, Portland
1996-1997	Silvia Cruz Mexico	Robert L. Balster Medical College of Virginia, Richmond
	Raka Jain India	Stephen G. Holtzman Emory University School of Medicine, Atlanta
	Danxin Wang China	Wolfgang Sadée University of California San Francisco
1995-1996	Bashir Ahmad Pakistan	Nissar Darmani Kirksville College of Osteopathic Medicine, Missouri
	Irena Martin-Kleiner Croatia	Jean M. Bidlack University of Rochester, New York
	Steve McGaraughty Canada	Mary Heinricher Oregon Health Sciences University, Portland
	Zhengxiong Xi China	Elliot A. Stein Medical College of Wisconsin, Milwaukee
1994-1995	Anton Bespalov Russia	Robert L. Balster Medical College of Virginia, Richmond
	Suchandra Ghosh India	Martin A. Adler Temple University School of Medicine, Philadelphia
	Ella Nikulina Russia	Klaus A. Miczek Tufts University, Boston
1993-1994	Yaprak Egilmez Turkey	Michael Emmett-Ogilsby Texas College of Osteopathic Medicine, Fort Worth
	Gerald Zernig Austria	James Woods University of Michigan Medical School, Ann Arbor